Skip to product information
1 of 1

Shulph Ink

Medication-Resistant Epilepsy: Diagnosis and Treatment

Medication-Resistant Epilepsy: Diagnosis and Treatment

Regular price £90.23 GBP
Regular price £93.99 GBP Sale price £90.23 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Medication-Resistant Epilepsy: Diagnosis and Treatment

Fifty million people worldwide have epilepsy, and up to 35% of patients experience seizures that are resistant to anti-epileptic drugs. This key resource provides guidance for clinicians to reduce the risks of premature death, psychosocial dysfunction, and reduced quality of life for patients with medication-resistant epilepsy. It covers epidemiology, biology, causes, and potential treatments, as well as treatment for specialized groups and non-pharmacologic interventions.

Format: Hardback
Length: 286 pages
Publication date: 10 September 2020
Publisher: Cambridge University Press


Epilepsy affects approximately 50 million people worldwide, and up to 35% of these patients face the challenge of experiencing seizures that remain resistant to anti-epileptic drugs. This significant population faces heightened risks, including premature death, psychosocial dysfunction, and a diminished quality of life. To mitigate these risks, this comprehensive and targeted text serves as a vital resource for clinicians involved in the care of patients with medication-resistant epilepsy. It provides a comprehensive overview of the epidemiology, biology, causes, and potential treatments for this condition, encompassing a wide range of clinical care needs. The guidance offered is practical and tailored to specialized groups, such as pediatric patients and those with psychiatric comorbidities. Additionally, the text delves into detailed exploration of several promising non-pharmacologic interventions, including surgery, neuromodulation diet therapy, and botanical treatment. Leading international experts from diverse disciplines come together in this essential manual, offering a holistic perspective on addressing medication-resistant epilepsy.
Epilepsy, a neurological disorder that affects approximately 50 million people worldwide, poses a significant challenge for patients as up to 35% encounter seizures that remain resistant to anti-epileptic drugs. This alarming statistic highlights the urgent need for effective treatment options and comprehensive clinical care. Patients with medication-resistant epilepsy face heightened risks, including premature death, psychosocial dysfunction, and a diminished quality of life. To address these risks, this comprehensive and targeted text serves as a vital resource for clinicians involved in the care of these individuals. It provides a comprehensive overview of the epidemiology, biology, causes, and potential treatments for medication-resistant epilepsy, encompassing a wide range of clinical care needs. The guidance offered is practical and tailored to specialized groups, such as pediatric patients and those with psychiatric comorbidities. Additionally, the text delves into detailed exploration of several promising non-pharmacologic interventions, including surgery, neuromodulation diet therapy, and botanical treatment. Leading international experts from diverse disciplines come together in this essential manual, offering a holistic perspective on addressing medication-resistant epilepsy.

Epilepsy, a neurological disorder that affects approximately 50 million people worldwide, poses a significant challenge for patients as up to 35% encounter seizures that remain resistant to anti-epileptic drugs. This alarming statistic highlights the urgent need for effective treatment options and comprehensive clinical care. Patients with medication-resistant epilepsy face heightened risks, including premature death, psychosocial dysfunction, and a diminished quality of life. To address these risks, this comprehensive and targeted text serves as a vital resource for clinicians involved in the care of these individuals. It provides a comprehensive overview of the epidemiology, biology, causes, and potential treatments for medication-resistant epilepsy, encompassing a wide range of clinical care needs. The guidance offered is practical and tailored to specialized groups, such as pediatric patients and those with psychiatric comorbidities. Additionally, the text delves into detailed exploration of several promising non-pharmacologic interventions, including surgery, neuromodulation diet therapy, and botanical treatment. Leading international experts from diverse disciplines come together in this essential manual, offering a holistic perspective on addressing medication-resistant epilepsy.

Weight: 756g
Dimension: 194 x 251 x 18 (mm)
ISBN-13: 9781107139886

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Germany, Spain, New Zealand and the United States of America.

  • Delivery times: within 5 - 20 business days when ordering to France, Germany, Ireland, Spain, Canada and the United States. Up to 30 business days for Australia and New Zealand.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details